These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12419373)

  • 1. Design and synthesis of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives as cysteine proteases inhibitors.
    Zhou NE; Guo D; Kaleta J; Purisima E; Menard R; Micetich RG; Singh R
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3413-5. PubMed ID: 12419373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Acylamino-penam derivatives: synthesis and inhibition of cathepsins B, L, K, and S.
    Zhou NE; Kaleta J; Purisima E; Menard R; Micetich RG; Singh R
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3417-9. PubMed ID: 12419374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.
    Zhou NE; Guo D; Thomas G; Reddy AV; Kaleta J; Purisima E; Menard R; Micetich RG; Singh R
    Bioorg Med Chem Lett; 2003 Jan; 13(1):139-41. PubMed ID: 12467634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.
    Myers MC; Shah PP; Beavers MP; Napper AD; Diamond SL; Smith AB; Huryn DM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3646-51. PubMed ID: 18499453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of selective and nonpeptidic cathepsin S inhibitors.
    Irie O; Ehara T; Iwasaki A; Yokokawa F; Sakaki J; Hirao H; Kanazawa T; Teno N; Horiuchi M; Umemura I; Gunji H; Masuya K; Hitomi Y; Iwasaki G; Nonomura K; Tanabe K; Fukaya H; Kosaka T; Snell CR; Hallett A
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3959-62. PubMed ID: 18572405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and L.
    Yamashita DS; Dong X; Oh HJ; Brook CS; Tomaszek TA; Szewczuk L; Tew DG; Veber DF
    J Comb Chem; 1999; 1(3):207-15. PubMed ID: 10746010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors.
    Altmann E; Renaud J; Green J; Farley D; Cutting B; Jahnke W
    J Med Chem; 2002 Jun; 45(12):2352-4. PubMed ID: 12036343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.
    Altmann E; Green J; Tintelnot-Blomley M
    Bioorg Med Chem Lett; 2003 Jun; 13(12):1997-2001. PubMed ID: 12781182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
    Löser R; Gütschow M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and parallel synthesis of a new class of cathepsin K inhibitors.
    Smith RA; Bhargava A; Browe C; Chen J; Dumas J; Hatoum-Mokdad H; Romero R
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2951-4. PubMed ID: 11677133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases.
    Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB
    J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
    J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
    Alper PB; Liu H; Chatterjee AK; Nguyen KT; Tully DC; Tumanut C; Li J; Harris JL; Tuntland T; Chang J; Gordon P; Hollenbeck T; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1486-90. PubMed ID: 16412634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cis-6-oxo-hexahydro-2-oxa-1,4-diazapentalene and cis-6-oxo-hexahydropyrrolo[3,2-c]pyrazole based scaffolds: design rationale, synthesis and cysteinyl proteinase inhibition.
    Wang Y; Benn A; Flinn N; Monk T; Ramjee M; Watts J; Quibell M
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1327-31. PubMed ID: 15713380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
    Löser R; Schilling K; Dimmig E; Gütschow M
    J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
    J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of chloromethyl sulfoxides as a new class of selective irreversible cysteine protease inhibitors.
    Brouwer AJ; Bunschoten A; Liskamp RM
    Bioorg Med Chem; 2007 Nov; 15(22):6985-93. PubMed ID: 17869119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity selection to papain yields potent peptide inhibitors of cathepsins L, B, H, and K.
    Bratkovic T; Lunder M; Popovic T; Kreft S; Turk B; Strukelj B; Urleb U
    Biochem Biophys Res Commun; 2005 Jul; 332(3):897-903. PubMed ID: 15913550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.
    Huang L; Ellman JA
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2993-6. PubMed ID: 12270191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.